LIN

Business Context and Reporting Period

Company: Linde PLC
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: Linde is a global leader in industrial gases and engineering, serving healthcare, chemicals, energy, manufacturing, and electronics sectors. The company operates through four reportable segments: Americas, EMEA, APAC, and Engineering.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 3% in Q3 2025 and 2% for the nine months ended September 30, 2025. Growth was driven by a 2% increase in price/mix and 1% from acquisitions. Currency translation contributed 1% in the quarter but was flat year-to-date.
• Profitability: Operating profit rose 13% in Q3 and 8% year-to-date. Adjusted operating profit (excluding merger accounting and cost reduction charges) increased 3% in Q3 and 4% year-to-date, reflecting higher pricing and productivity gains offsetting cost inflation.
• Cost Structure: Cost of sales (excluding D&A) remained stable as a percentage of sales (50.8% in Q3 vs. 52.1% in Q3 2024) due to pricing power and productivity. SG&A increased 9% in Q3, partly due to currency impacts and acquisitions.
• Segment Performance:
  • Americas: Sales +6% (Q3), driven by price (+3%) and cost pass-through (+2%).
  • EMEA: Sales +3% (Q3), driven by currency (+5%) and price (+2%), despite volume declines (-3%).
  • APAC: Sales +1% (Q3), with flat volumes offset by acquisitions (+3%).
  • Engineering: Sales -15% (Q3) due to project timing.
• Tax Rate: The reported effective tax rate decreased to 18.0% in Q3 2025 from 24.1% in Q3 2024, primarily due to tax rate decreases in EMEA.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management provides quarterly updates via earnings releases and investor teleconferences but does not provide specific numerical guidance in this filing. The company expects continued investment in new plant and production equipment to meet backlog growth.
• Capital Allocation:
  • Dividends: Quarterly dividend increased 8% to $1.50 per share.
  • Share Repurchases: $3.2 billion in shares repurchased in the first nine months of 2025. Approximately $8.7 billion remains authorized under the 2023 program.
  • Capital Expenditures: $3.8 billion for the nine months ended September 30, 2025, up from $3.2 billion in the prior year period.
• Legal Proceedings & Contingencies:
  • Russia: Significant ongoing disputes with RusChemAlliance (RCA) and Gazprom regarding engineering projects (Amur GPP and LNG). Linde has recorded $1.9 billion in liabilities related to these matters as of September 30, 2025. Local Russian courts have ordered the sale of Linde's Russian joint ventures, with proceeds paid to RCA.
  • Brazil: Ongoing litigation regarding tax disputes under the Refis Program; final resolution timing is uncertain.
  • Germany: Appraisal proceedings regarding the 2019 Linde AG merger squeeze-out are on appeal; no reserve established.
• Unusual Items: Q3 2025 included a benefit of $11 million from cost reduction programs, compared to charges of $145 million in Q3 2024. The 2024 period also included a $36 million supplier settlement benefit in the Americas.

Investor Verification Checklist

• Russia Exposure: Verify the status of the $1.9 billion liability and the potential for further asset seizures or legal judgments in Russia.
• Volume Trends: Monitor volume declines in EMEA (-3% to -4%) and APAC (-1%) to assess demand in metals, mining, and manufacturing sectors.
• Engineering Backlog: Confirm the $7.1 billion sale of gas backlog and the timing of project start-ups to offset recent Engineering sales declines.
• Currency Sensitivity: Assess the impact of the strengthening Euro and British Pound on reported results versus underlying operational performance.
• Debt Maturity: Review the debt schedule, noting the issuance of new Euro and Swiss Franc notes in 2025 and the repayment of maturing U.S. dollar notes.